Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study
Keyword(s):
Phase Ii
◽
1991 ◽
Vol 27
(12)
◽
pp. 1583-1589
◽
2008 ◽
Vol 31
(3)
◽
pp. 237-243
◽